bosentan anhydrous has been researched along with Uveitis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bağrıaçık, EÜ; Dileköz, E; Ercan, S; Karaca, EE; Kul, O; Or, M; Öztürk Fincan, GS; Uzun, F | 1 |
Akpinar, E; Altuner, D; Atmaca, HT; Bayraktutan, Z; Cakici, O; Ekinci, M; Halici, Z; Keles, S; Yayla, M; Yildirim, K | 1 |
2 other study(ies) available for bosentan anhydrous and Uveitis
Article | Year |
---|---|
The effect of endothelin receptor antagonists in the endotoxin-induced uveitis rabbit model
Topics: Animals; Aqueous Humor; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Eye; Eye Proteins; Intravitreal Injections; Leukocyte Count; Lipopolysaccharides; Male; Peptides, Cyclic; Rabbits; Sulfonamides; Uveitis | 2018 |
The ocular endothelin system: a novel target for the treatment of endotoxin-induced uveitis with bosentan.
Topics: Animals; Aqueous Humor; Bosentan; Dexamethasone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endothelins; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glucocorticoids; Male; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Receptors, Endothelin; RNA; Sulfonamides; Treatment Outcome; Uveitis | 2014 |